186 related articles for article (PubMed ID: 36712973)
1. Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis.
Kang J; Xiang X; Chen X; Jiang J; Zhang Y; Li L; Tang J
Front Cell Dev Biol; 2022; 10():1086835. PubMed ID: 36712973
[TBL] [Abstract][Full Text] [Related]
2. A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
Xiang X; Kang J; Jiang J; Zhang Y; Zhang Y; Li L; Peng X
Front Immunol; 2023; 14():1198391. PubMed ID: 37449209
[TBL] [Abstract][Full Text] [Related]
3. Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis.
Kang J; Jiang J; Xiang X; Zhang Y; Tang J; Li L
Cancer Cell Int; 2024 Jan; 24(1):23. PubMed ID: 38200479
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a prognostic model for cervical cancer by combination of machine learning and high-throughput sequencing.
Shi R; Chang L; Shi L; Zhang Z; Zhang L; Li X
Eur J Surg Oncol; 2024 Apr; 50(4):108241. PubMed ID: 38452717
[TBL] [Abstract][Full Text] [Related]
5. Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis.
Li X; Yang X; Xue W; Yang R; He Z; Ai L; Liu H
Front Oncol; 2023; 13():1119763. PubMed ID: 37064125
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification.
Bi Y; Jing Y; Guo L
Front Genet; 2022; 13():1017551. PubMed ID: 36263426
[No Abstract] [Full Text] [Related]
7. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
8. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
9. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
Li R; Zhao W; Liang R; Jin C; Xiong H
Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
[No Abstract] [Full Text] [Related]
11. Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer.
Pi YN; Guo JN; Lou G; Cui BB
Cancer Cell Int; 2021 Dec; 21(1):639. PubMed ID: 34852825
[TBL] [Abstract][Full Text] [Related]
12. Determination of a six-gene prognostic model for cervical cancer based on WGCNA combined with LASSO and Cox-PH analysis.
Li S; Han F; Qi N; Wen L; Li J; Feng C; Wang Q
World J Surg Oncol; 2021 Sep; 19(1):277. PubMed ID: 34530829
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer.
Su R; Jin C; Bu H; Xiang J; Zhou L; Jin C
Front Oncol; 2022; 12():861392. PubMed ID: 35651784
[TBL] [Abstract][Full Text] [Related]
14. Constructe a novel 5 hypoxia genes signature for cervical cancer.
Yang Y; Li Y; Qi R; Zhang L
Cancer Cell Int; 2021 Jul; 21(1):345. PubMed ID: 34217310
[TBL] [Abstract][Full Text] [Related]
15. Construction of a Six-Gene Prognostic Risk Model Related to Hypoxia and Angiogenesis for Cervical Cancer.
Liu L; Zhu H; Wang P; Wu S
Front Genet; 2022; 13():923263. PubMed ID: 35769999
[No Abstract] [Full Text] [Related]
16. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
Front Oncol; 2022; 12():857994. PubMed ID: 35619896
[TBL] [Abstract][Full Text] [Related]
17. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
Front Immunol; 2022; 13():943389. PubMed ID: 36003381
[TBL] [Abstract][Full Text] [Related]
18. Immune-related gene signature to predict TACE refractoriness in patients with hepatocellular carcinoma based on artificial neural network.
Xu Q; Wang C; Yin G
Front Genet; 2022; 13():993509. PubMed ID: 36685822
[No Abstract] [Full Text] [Related]
19. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
20. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
Wang Y; Zhang L; Wang B; Cheng Y
Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
